Alternatively spliced tissue factor and full-length tissue factor protect cardiomyocytes against TNF-α-induced apoptosis

Journal of Molecular and Cellular Cardiology

Volumn 52, Issue 5, 2012, Pages 1056-1065

  Boltzen, U ^a,b   Eisenreich, A ^a   Antoniak, S ^c   Weithaeuser, A ^a,b   Fechner, H ^a   Poller, W ^a   Schultheiss, H P ^a   Mackman, N ^c   Rauch, U ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cardiomyocytes; Inflammation; Signaling; Tissue Factor

Indexed keywords

CASPASE 3; CASPASE 9; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; LIPOCORTIN 5; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLSERINE; PROPIDIUM IODIDE; PROTEIN BCL XL; PROTEIN KINASE B; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA; VITRONECTIN RECEPTOR;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ASSAY; CELL DEATH; CELL STIMULATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; GENE EXPRESSION; HEART MUSCLE CELL; HEART PROTECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; SIGNAL TRANSDUCTION; UPREGULATION; WILD TYPE;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; CELL LINE; GENE EXPRESSION; MAP KINASE SIGNALING SYSTEM; MICE; MYOCYTES, CARDIAC; NF-KAPPA B; PHOSPHORYLATION; PRIMARY CELL CULTURE; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-BCL-2; THROMBOPLASTIN; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

MURINAE;

EID: 84859638547     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.01.015     Document Type: Article

References (49)

1. Rauch U., Bonderman D., Bohrmann B., Badimon J.J., Himber J., Riederer M.A., et al. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood 2000, 96:170-175.
2. Giesen P.L., Rauch U., Bohrmann B., Kling D., Roque M., Fallon J.T., et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A 1999, 96:2311-2315.
3. Rauch U., Nemerson Y. Circulating tissue factor and thrombosis. Curr Opin Hematol 2000, 7:273-277.
4. Rauch U., Nemerson Y. Tissue factor, the blood, and the arterial wall. Trends Cardiovasc Med 2000, 10:139-143.
5. Antoniak S., Boltzen U., Eisenreich A., Stellbaum C., Poller W., Schultheiss H.P., et al. Regulation of cardiomyocyte full-length tissue factor expression and microparticle release under inflammatory conditions in vitro. J Thromb Haemost 2009, 7:871-878.
6. Pawlinski R., Tencati M., Holscher T., Pedersen B., Voet T., Tilley R.E., et al. Role of cardiac myocyte tissue factor in heart hemostasis. J Thromb Haemost 2007, 5:1693-1700.
7. Luther T., Dittert D.D., Kotzsch M., Erlich J., Albrecht S., Mackman N., et al. Functional implications of tissue factor localization to cell-cell contacts in myocardium. J Pathol 2000, 192:121-130.
8. Bogdanov V.Y., Balasubramanian V., Hathcock J., Vele O., Lieb M., Nemerson Y. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med 2003, 9:458-462.
9. Bogdanov V.Y., Kirk R.I., Miller C., Hathcock J.J., Vele S., Gazdoiu M., et al. Identification and characterization of murine alternatively spliced tissue factor. J Thromb Haemost 2006, 4:158-167.
10. Szotowski B., Antoniak S., Rauch U. Alternatively spliced tissue factor: a previously unknown piece in the puzzle of hemostasis. Trends Cardiovasc Med 2006, 16:177-182.
11. Szotowski B., Antoniak S., Poller W., Schultheiss H.P., Rauch U. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ Res 2005, 96:1233-1239.
12. Szotowski B., Antoniak S., Goldin-Lang P., Tran Q.V., Pels K., Rosenthal P., et al. Antioxidative treatment inhibits the release of thrombogenic tissue factor from irradiation- and cytokine-induced endothelial cells. Cardiovasc Res 2007, 73:806-812.
13. van den Berg Y.W., van den Hengel L.G., Myers H.R., Ayachi O., Jordanova E., Ruf W., et al. Alternatively spliced tissue factor induces angiogenesis through integrin ligation. Proc Natl Acad Sci U S A 2009, 106:19497-19502.
14. Eisenreich A., Celebi O., Goldin-Lang P., Schultheiss H.P., Rauch U. Upregulation of tissue factor expression and thrombogenic activity in human aortic smooth muscle cells by irradiation, rapamycin and paclitaxel. Int Immunopharmacol 2008, 8:307-311.
15. Eisenreich A., Bogdanov V.Y., Zakrzewicz A., Pries A., Antoniak S., Poller W., et al. Cdc2-like kinases and DNA topoisomerase I regulate alternative splicing of tissue factor in human endothelial cells. Circ Res 2009, 104:589-599.
16. Szotowski B., Goldin-Lang P., Antoniak S., Bogdanov V.Y., Pathirana D., Pauschinger M., et al. Alterations in myocardial tissue factor expression and cellular localization in dilated cardiomyopathy. J Am Coll Cardiol 2005, 45:1081-1089.
17. Hobbs J.E., Zakarija A., Cundiff D.L., Doll J.A., Hymen E., Cornwell M., et al. Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model. Thromb Res 2007, 120(Suppl. 2):S13-S21.
18. Versteeg H.H., Schaffner F., Kerver M., Petersen H.H., Ahamed J., Felding-Habermann B., et al. Inhibition of tissue factor signaling suppresses tumor growth. Blood 2008, 111:190-199.
19. Versteeg H.H., Spek C.A., Slofstra S.H., Diks S.H., Richel D.J., Peppelenbosch M.P. FVIIa:TF induces cell survival via G12/G13-dependent Jak/STAT activation and BclXL production. Circ Res 2004, 94:1032-1040.
20. Aberg M., Wickstrom M., Siegbahn A. Simvastatin induces apoptosis in human breast cancer cells in a NFkappaB-dependent manner and abolishes the anti-apoptotic signaling of TF/FVIIa and TF/FVIIa/FXa. Thromb Res 2008, 122:191-202.
21. Versteeg H.H., Borensztajn K.S., Kerver M.E., Ruf W., Reitsma P.H., Spek C.A., et al. TF:FVIIa-specific activation of CREB upregulates proapoptotic proteins via protease-activated receptor-2. J Thromb Haemost 2008, 6:1550-1557.
22. Perman J.C., Boström P., Lindbom M., Lidberg U., Ståhlman M., Hägg D., et al. The VLDL receptor promotes lipotoxicity and increases mortality in mice following an acute myocardial infarction. J Clin Invest 2011, 121:2625-2640.
23. Loubele S.T., Spek C.A., Leenders P., van Oerle R., Aberson H.L., van der Voort D., et al. Active site inhibited factor VIIa attenuates myocardial ischemia/reperfusion injury in mice. J Thromb Haemost 2009, 7:290-298.
24. Hamid T., Guo S.Z., Kingery J.R., Xiang X., Dawn B., Prabhu S.D. Cardiomyocyte NF-κB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure. Cardiovasc Res 2011, 89:129-138.
25. Claycomb W.C., Lanson N.A., Stallworth B.S., Egeland D.B., Delcarpio J.B., Bahinski A., et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci U S A 1998, 95:2979-2984.
26. Yan L., Tang Q., Shen D., Peng S., Zheng Q., Guo H., et al. SOCS-1 inhibits TNF-alpha-induced cardiomyocyte apoptosis via ERK1/2 pathway activation. Inflammation 2008, 31:180-188.
27. Kong J.Y., Rabkin S.W. Thapsigargin enhances camptothecin-induced apoptosis in cardiomyocytes. Pharmacol Toxicol 1999, 85:212-220.
28. Scabini M., Stellari F., Cappella P., Rizzitano S., Texido G., Pesenti E. In vivo imaging of early stage apoptosis by measuring real-time caspase-3/7 activation. Apoptosis 2011, 16:198-207.
29. Eisenreich A., Rauch U. PI3K inhibitors in cardiovascular disease. Cardiovasc Ther 2011, 29:29-36.
30. Teshima Y., Akao M., Jones S.P., Marbán E. Uncoupling protein-2 overexpression inhibits mitochondrial death pathway in cardiomyocytes. Circ Res 2003, 93:192-200.
31. Ventéo L., Bourlet T., Renois F., Douche-Aourik F., Mosnier J.F., Maison G.L., et al. Enterovirus-related activation of the cardiomyocyte mitochondrial apoptotic pathway in patients with acute myocarditis. Eur Heart J 2010, 31:728-736.
32. Bajaj G., Sharma R.K. TNF-alpha-mediated cardiomyocyte apoptosis involves caspase-12 and calpain. Biochem Biophys Res Commun 2006, 345:1558-1564.
33. Gessler F., Voss V., Dutzmann S., Seifert V., Gerlach R., Kogel D. Inhibition of tissue factor/protease-activated receptor-2 signaling limits proliferation, migration and invasion of malignant glioma cells. Neuroscience 2010, 165:1312-1322.
34. Eisenreich A., Malz R., Pepke W., Ayral Y., Poller W., Schultheiss H.P., et al. Role of the phosphatidylinositol 3-kinase/protein kinase B pathway in regulating alternative splicing of tissue factor mRNA in human endothelial cells. Circ J 2009, 73:1746-1752.
35. Fujio Y., Nguyen T., Wencker D., Kitsis R.N., Walsh K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 2000, 101:660-667.
36. Matsui T., Li L., del Monte F., Fukui Y., Franke T.F., Hajjar R.J., et al. Adenoviral gene transfer of activated phosphatidylinositol 3'-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. Circulation 1999, 100:2373-2379.
37. Zheng J., Koh X., Hua F., Li G., Larrick J.W., Bian J.S. Cardioprotection induced by Na(+)/K(+)-ATPase activation involves extracellular signal-regulated kinase 1/2 and phosphoinositide 3-kinase/Akt pathway. Cardiovasc Res 2011, 89:51-59.
38. Griffiths G.S., Grundl M., Leychenko A., Reiter S., Young-Robbins S.S., Sulzmaier F.J., et al. Bit-1 mediates integrin-dependent cell survival through activation of the NFkappaB pathway. J Biol Chem 2011, 286:14713-14723.
39. Song G., Ming Y., Mao Y., Bao S., Ouyang G. Osteopontin prevents curcumin-induced apoptosis and promotes survival through Akt activation via alpha v beta 3 integrins in human gastric cancer cells. Exp Biol Med (Maywood) 2008, 233:1537-1545.
40. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997, 91:231-241.
41. Banu S.K., Lee J., Speights V.O., Starzinski-Powitz A., Arosh J.A. Selective inhibition of prostaglandin E2 receptors EP2 and EP4 induces apoptosis of human endometriotic cells through suppression of ERK1/2, AKT, NFkappaB, and beta-catenin pathways and activation of intrinsic apoptotic mechanisms. Mol Endocrinol 2009, 23:1291-1305.
42. Fang J., Gu L., Zhu N., Tang H., Alvarado C.S., Zhou M. Tissue factor/FVIIa activates Bcl-2 and prevents doxorubicin-induced apoptosis in neuroblastoma cells. BMC Cancer 2008, 8:69.
43. Borillo G.A., Mason M., Quijada P., Völkers M., Cottage C., McGregor M., et al. Pim-1 kinase protects mitochondrial integrity in cardiomyocytes. Circ Res 2010, 106:1265-1274.
44. Chen Z., Chua C.C., Ho Y.S., Hamdy R.C., Chua B.H. Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. Am J Physiol Heart Circ Physiol 2001, 280:H2313-H2320.
45. Kirshenbaum L.A., De M.D. The bcl-2 gene product prevents programmed cell death of ventricular myocytes. Circulation 1997, 96:1580-1585.
46. Huang J., Nakamura K., Ito Y., Uzuka T., Morikawa M., Hirai S., et al. Bcl-xL gene transfer inhibits Bax translocation and prolongs cardiac cold preservation time in rats. Circulation 2005, 112:76-83.
47. Pawlinski R., Fernandes A., Kehrle B., Pedersen B., Parry G., Erlich J., et al. Tissue factor deficiency causes cardiac fibrosis and left ventricular dysfunction. Proc Natl Acad Sci U S A 2002, 99:15333-15338.
48. Srinivasan R, Ozhegov E, van den Berg YW, Aronow BJ, Franco RS., Palascak MB, et al. Splice variants of tissue factor promote monocyte-endothelial interactions by triggering the expression of cell adhesion molecules via integrin-mediated signaling. J Thromb Haemost 2011, 9:2087-2096.
49. Eisenreich A., Boltzen U., Malz R., Schultheiss H.P., Rauch U. Overexpression of alternatively spliced tissue factor induces the pro-angiogenic properties of murine cardiomyocytic HL-1 cells. Circ J 2011, 75:1235-1242.